News & Articles

A focused clinical approach to second-generation anti-seizure medications and laboratory diagnostics

With global colorectal cancer rates on the rise, healthcare systems need smarter ways to screen patients. FIT testing is proving to be one of the most effective and efficient tools at their disposal.

New solutions from Siemens Healthineers address labs’ environmental and efficiency goals

Discover how thyroid stimulating immunoglobulin (TSI) testing enhances differentiation of Graves’ disease from other hyperthyroid conditions — enabling precise diagnoses and better patient care

New clinical insights reveal how this protein helps diagnose, monitor, and predict flare-ups in rheumatic diseases

Measuring antithrombin activity levels helps people receive the appropriate dose, initially and over time

The INNOVANCE Anti-Xa assay for anticoagulant therapy management delivers fully automated, ready-to-use testing for heparins, rivaroxaban, apixaban, and edoxaban

The first cleared troponin assay in the U.S. for longer-term prognostic insights

Discover how Siemens Healthineers is breaking down barriers and making automation more accessible, efficient, and beneficial for clinical labs of all sizes

This high-sensitivity troponin test from Siemens Healthineers is the only one in the US with a prognostic risk intended use

Discover how sustainability, efficiency, automation and other trends are impacting diagnostic innovation and improving healthcare outcomes

Optimism that automation and AI will help tackle challenges

At the ADLM 2024 Clinical Lab Expo (July 28–August 1, Chicago, Booth #501), Siemens Healthineers will demonstrate what is achievable for laboratory testing with human-centered engineering and automation.

NT‑proBNPII Assay now part of Atellica cardiac testing menu

Professor of Emergency Medicine at the University of Manchester highlights the promise of point-of-care high-sensitivity troponin assays in the emergency department

New blood test developed by Siemens Healthineers in collaboration with Novartis aims to improve the management of MS

The Anti-Müllerian Hormone Assay reveals a patient's ovarian reserve information

The new compact testing system is designed to tackle a range of challenges faced by today's laboratories

Removes workflow barriers to improve patient care

Rapid antigen testing provides results in just 15 minutes and the information can help reduce the risk of COVID-19 exposure

The lab-based Atellica and ADVIA Centaur SARS-CoV-2 Antigen Assays (CoV2Ag) are well designed to detect Omicron variant

The fully automated CN-3000 and CN-6000 Systems bring mid- and high-volume coagulation testing to laboratories